LinusBio
PrivateLast Round
VC Round
Jun 16, 2025
Est. Valuation
$170M
Total Funding Raised
$24M
Company Overview
LinusBio operates in Healthcare & Life Sciences and is based in New Jersey. Its latest recorded funding round was a VC Round in June 2025.
LinusBio is a biotechnology company that provides a precision exposome medicine platform to analyze the molecular impact of environmental exposures on health, with applications in diagnosing and treating complex disorders.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LinusBio Comparables
Compare LinusBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MARAbio | 81% | |
| BioROSA Technologies | 79% | |
| NeuroQure | 78% |
For institutional investors. Book with your work email.
LinusBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 16, 2025 | ||||
| VC Round | Aug 12, 2024 | ||||
| Series A Extension | May 31, 2023 | ||||
| Series A | Jan 12, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
LinusBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series A |
| GreatPoint Ventures | Series A |
| Bow Capital | Series A Extension, Series A |
| Divergent Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 5, 2025
Partnered with Coralis Health to advance autism detection.
- Jun 16, 2025
$3M raised in a VC Round.
For institutional investors. Book with your work email.
LinusBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about LinusBio's valuation, stock price, and market status.
Is LinusBio a public or private company?
LinusBio is a private company.
What is the current stock price of LinusBio?
LinusBio is a private company, so its shares have no public market price. Caplight tracks LinusBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is LinusBio worth (valuation)?
LinusBio's valuation is estimated at $170.0M based on funding round data.
Can I buy LinusBio stock?
LinusBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was LinusBio's last funding round?
LinusBio's most recent funding round was VC Round on June 16, 2025.
Who are the main investors in LinusBio?
Key investors in LinusBio include GreatPoint Ventures, GreatPoint Ventures, Bow Capital.
Will LinusBio IPO soon?
No public IPO plans have been announced for LinusBio.
How can I track LinusBio secondary market activity?
Caplight tracks bids, offers, and trades in LinusBio's shares on secondary markets.